Diversity Oriented Synthesis Conference ***BOOK NOW FOR THE FEW REMAINING PLACES*** 22-23 September 2005 Waltham, Boston, USA
Last Updated on Thursday, 11 August 2005 12:30 Written by admin Thursday, 11 August 2005 12:30
The inaugural conference on Diversity Oriented Synthesis provides an in-depth analysis of the current thinking and latest technologies within this field. This highly targeted event has captured the imagination of the industry and has proved to be very popular so far. Don’t miss this opportunity to network with the leading institutions from around the world.
***REGISTER FROM ONLY $399***
Organisations already confirmed:
Alchemia Limited – ArQule, Inc. – AstraZeneca R&D Boston – BASF Aktiengesellschaft – Biogen Idec – Boehringer Ingelheim Pharma GmbH – Boston University – Bristol-Myers Squibb PRI – Broad Institute of Harvard and MIT – Cephalon, Inc. – ChemDiv, Inc. – Chemspeed Technologies – CytRx Laboratories – Discovery Abbott Laboratories – Evotec OAI Ltd – F. Hoffmann-La Roche – Genomics Institute of the Novartis Research Foundation – Genzyme, Corp. – GlaxoSmithKline – Harvard Medical School – Hebrew University Jerusalem Israel – IIT Kanpur – Institute of Materia Medica – Johnson & Johnson Research Pty Ltd – LEK d.d. – Lilly Corporate Center – Merck Sante – Neurogen Corp – OSI Pharmaceuticals Inc – Reliance R & D Services Pvt Ltd – Sanofi-Aventis – Schering AG – Scripps Research Institute – Scynexis, Inc – Solvay Pharmaceuticals – Steacie Institute for Molecular Sciences – Syngenta – Takeda Pharmaceutical Company Ltd – Tripos Discovery Research Ltd – University of Cambridge – University of Florence – University of
Heidelberg – University of Hull – University of Notre Dame – University of Pittsburgh Center for Chemical Methodologies & Library Development (UPCMLD) – University of Washington & Institute for Chemical Genomics – Vertex Pharmaceuticals.
Exhibitors already confirmed
– Alchemia – Corporate Sponsor
– Worldwide Glass Resourses
– Mettler Toledo
Further details available through the following links:
Full Agenda http://www.selectbiosciences.com/conferences/DOS/Detailed_Agenda.aspx
Conference Brochure https://selectbiosciences.com/conferences/files/DOS%20brochure.pdf
Registration https://selectbiosciences.com/conferences/DOS/booking/register.aspx
===============================================================================================
Agenda Sessions and Speakers:
Day One: 22nd September
08:30 NOVEL SYNTHETIC METHODOLOGIES
Chaired by Dr. Gerard Rosse, Sanofi-aventis
- Dr. Bruce Clapham, Discovery Abbott Laboratories
- Prof. Thomas J. J. Mueller, University of Heidelberg
- Dr. Viktor Krchnak, University of Notre Dame
- Dr. Wim Meutermans, Alchemia Limited
- Dr. Jared Shaw, Broad Institute of Harvard and MIT
- Prof. Gang Liu, Institute of Materia Medica
————————————
13:50 HIGH THROUGHPUT STRATEGIES
Chaired by Dr. Thierry Masquelin, Lilly Corporate Center
- Dr. Andreas Termin, Vertex Pharmaceuticals Incorporated
- Dr. Rainer Martin, F. Hoffmann-La Roche
- Dr. Josef Schröer, Chemspeed Technologies
- Dr. Michael Kahn, University of Washington & Institute for Chemical Genomics
- Dr. Thierry Masquelin, Lilly Corporate Center
***************************
Day Two: 23rd September
08:30 DESIGN AND SYNTHESIS APPROACHES
Chaired by Dr. Joseph M. Salvino, Cephalon, Inc.
- Dr. Joseph M. Salvino, Cephalon, Inc.
- KEYNOTE: Dr. John A. Porco, Jr., Boston University
- Dr. Alex Kiselyov, ChemDiv, Inc.
- Dr. John Y. Zhang, CytRx Laboratories
- Dr. Stephan C. Schürer, Scripps Research Institute.
- Dr. Prabhat Arya, Steacie Institute for Molecular Sciences, National Research Council of Canada
————————————
13:50 ADVANCES IN LIBRARY PURIFICATION
Chaired by Dr. John Isbell, Genomics Institute of the Novartis Research Foundation
- Dr. John J. Isbell, Genomics Institute of the Novartis Research Foundation
- Dr. Wolfgang K. Goetzinger, ArQule, Inc.
- Dr. Marcus Koppitz, Schering AG
- Dr. Paul Watts, University of Hull
- Dr. Stefan Werner, University of Pittsburgh Center for Chemical Methodologies & Library Development (UPCMLD)
===============================================================================================
Full Agenda available online at: http://www.selectbiosciences.com/conferences/DOS/Detailed_Agenda.aspx
===============================================================================================
In order to ensure the widest possible audience for our speakers, registration fees start at just $399, making this conference an absolute must if you want to see the latest research and equipment in diversity oriented synthesis whilst networking with your peers.
Best regards
Virginie Colcombet
Conference Manager
Main Menu
- Home
- About Bioscreening.net
- Glossary
- Biotechnology Glossary A-I
- Biotechnology Glossary J-Q
- Biotechnology Glossary R-Z
- Bird Flu
- Cheminformatic Glossary
- Endotoxins
- Fullerenes
- Genipin
- Gossypol (Gossipol)
- Grants, Venture Capital, and Government Funding
- High-throughput screening
- Lipinski Rule-of-Five
- Mumie
- Natural Medicine
- Rule-of-Three (Ro3)
- Targeted Libraries
- Web Directory